Company: CRVO
Filing Date: 2025-04-29
Form Type: DEF 14A
Source: 0001437749-25-013543
Chunk: 39

Company: CervoMed Inc.
Filing Date: 2025-04-29
Form: DEF 14A
Chunk 39
---
934 |     |               |      0 |     | $         | 61.50 |     | 9/22/2030  |
|                               |     |             |   1,169 |     |               |      0 |     | $         | 83.25 |     | 3/1/2031   |
|                               |     |             |   278** |     |               |      0 |     | $         | 83.25 |     | 3/1/2031   |
|                               |     |             |   4,076 |     |               |      0 |     | $         | 18.00 |     | 1/27/2032  |
|                               |     |             |   7,111 |     |               |  8,889 |     | $         |  5.33 |     | 9/15/2033  |
|                               |     |             |   5,333 |     |               | 10,667 |     | $         |  9.24 |     | 1/26/2034  |

* Granted pursuant to the 2018 Equity Plan, which was assumed by the Company in accordance with and pursuant to the terms of the Merger Agreement.

** Pursuant to the terms of the corresponding award agreements, two-thirds of the underlying shares originally granted were automatically forfeited on October 1, 2021, due to non-achievement of certain specified performance metrics.

All of the option grants to Drs. Alam and Cobuzzi and Mr. Elder described in the table above subject to future vesting vest and become exercisable in equal monthly installments over a 36-month period until fully vested, subject to the executive’s continued employment through the applicable vesting date. In connection with the conclusion of Dr. Cobuzzi’s employment, the Company and Dr. Cobuzzi intend to enter the Separation Agreement, which provides that, among other things, notwithstanding any terms of the 2015 Equity Plan or any stock option award agreements to the contrary, all Company stock options previously granted to Dr. Cobuzzi will remain exercisable and continue to vest in accordance with their respective vesting schedules through September 30, 2026.

401(k) Retirement Plan

We maintain our 401(k) Plan pursuant to which all eligible employees are entitled to make pre-tax and after-tax contributions of their compensation. In addition, the Company